 |
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2025, vol. 31, issue3
Subject Area: Dental Medicine
-
DOI: 10.5272/jimab.2025313.6438
Published online: 09 September 2025
Review article
J of IMAB. 2025 Jul-Sep;31(3):6438-6441
THE ROLE OF microRNA IN PERIODONTITIS AND HYPERTENSION
Theodora Bolyarova
,
Department of Periodontology, Faculty of Dental Medicine, Medical University - Sofia, Bulgaria.
ABSTRACT:
Periodontitis is a socially significant disease due to its potential to locally cause tooth loss and impaired function, and systemically, due to its influence on the onset and progression of various chronic diseases. Hypertension is socially significant because of its widespread prevalence and its potential to cause damage to various organs.
MicroRNAs (miRNA) are involved in various immune and inflammatory response processes as post-transcriptional blockers that bind to mRNA and silence specific target genes. One of the mechanisms by which periodontitis may affect other systemic diseases, such as cardiovascular diseases, including hypertension, is believed to be due to changes in serum miRNA levels caused by periodontal infection. Such aberrant miRNA expression can impact signaling cascades related to immune mechanisms, potentially triggering chronic diseases involving inflammatory processes in their pathogenesis.
Contemporary research focuses on identifying changes in miRNA expression associated with these pathologies, exploring their potential as next-generation biomarkers for early diagnosis, confirming shared signaling pathways between periodontal diseases and hypertension, and guiding the development of novel molecular therapeutic strategies. The significance of such scientific studies lies in their expected contribution to addressing public health challenges such as hypertension and periodontitis.
Keywords: microRNAs, Periodontitis, Hypertension, Next-generation sequencing,
- Download FULL TEXT /PDF 484 KB/
Please cite this article as: Bolyarova T. The role of microRNA in periodontitis and hypertension. J of IMAB. 2025 Jul-Sep;31(3):6438-6441. [Crossref - 10.5272/jimab.2025313.6438]
Correspondence to: Theodora Nikolaeva Bolyarova, Department of Periodontology, Faculty of Dental Medicine, Medical University – Sofia; 1, St. G. Sofiiski Blvd., 1431 Sofia, Bulgaria; E-mail: t.bolyarova@fdm.mu-sofia.bg
REFERENCES:
1. Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M, Fine DH, et al. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018 Jun;89 Suppl 1:S173-S182. [PubMed]
2. Bartold PM, Van Dyke TE. Host modulation: controlling the inflammation to control the infection. Periodontol 2000. 2017 Oct;75(1):317-329. [PubMed]
3. Page IH. The mosaic theory of arterial hypertension-its interpretation. Perspect Biol Med. 1967 Spring;10(3):325-33. [PubMed]
4. Huo KG, Fraulob-Aquino JC, Barhoumi T, Richer C, Coelho SC, Ouerd S, et al. In vivo miR-431 Inhibition Protects Against Vascular Damage and Hypertension. Hypertension. 2017 Sep;70(Suppl 1):162. [Crossref]
5. Zhang C, Xue P, Ke J, Cai Q. Development of Ferroptosis-Associated ceRNA Network in Periodontitis. Int Dent J. 2023 Apr;73(2):186-194. [PubMed]
6. Cuevas-González MV, Suaste-Olmos F, García-Calderón AG, Tovar-Carrillo KL, Espinosa-Cristóbal LF, Nava-Martínez SD, et al. Expression of MicroRNAs in Periodontal Disease: A Systematic Review. Biomed Res Int. 2021 Jan 19;2021:2069410. [PubMed]
7. Hu T, Chitnis N, Monos D, Dinh A. Next-generation sequencing technologies: An overview. Hum Immunol. 2021 Nov;82(11):801-811. [PubMed]
8. Öngöz Dede F, Gökmenoğlu C, Türkmen E, Bozkurt Doğan Ş, Ayhan BS, Yildirim K. Six miRNA expressions in the saliva of smokers and non-smokers with periodontal disease. J Periodontal Res. 2023 Feb;58(1):195-203. [PubMed ]
9.Buragaite-Staponkiene B, Rovas A, Puriene A, Snipaitiene K, Punceviciene E, Rimkevicius A, et al. Gingival Tissue MiRNA Expression Profiling and an Analysis of Periodontitis-Specific Circulating MiRNAs. Int J Mol Sci. 2023 Jul 26;24(15):11983. [PubMed]
10. Elazazy O, Amr K, Abd El Fattah A, Abouzaid M. Evaluation of serum and gingival crevicular fluid microRNA-223, microRNA-203 and microRNA-200b expression in chronic periodontitis patients with and without diabetes type 2. Arch Oral Biol. 2021 Jan;121:104949. [PubMed]
11. Luan X, Zhou X, Fallah P, Pandya M, Lyu H, Foyle D, et al. MicroRNAs: Harbingers and shapers of periodontal inflammation. Semin Cell Dev Biol. 2022 Apr;124:85-98. [PubMed]
12. Xu X, Lang GP, Chen ZL, Wang JL, Han YY. The Dual Role of Non-coding RNAs in the Development of Periodontitis. Biomed Environ Sci. 2023 Aug 20;36(8):743-755. [Crossref]
13. Huo KG, Fraulob-Aquino JC, Richer C, Rehman A, Briet M, Boutouyrie P, et al. MicroRNA Profiling in Peripheral Blood Mononuclear Cells From Hypertensive Patients With or Without Chronic Kidney Disease. Hypertension. 2017 Sep;70(Suppl_1): p158. [Crossref]
14. Sun Y, Shang Q. Research hotspots and trends regarding microRNAs in hypertension: a bibliometric analysis. Clin Exp Hypertens. 2024 Dec 31;46(1):2304017. [PubMed]
15. Tada A, Tano R, Miura H. The relationship between tooth loss and hypertension: a systematic review and meta-analysis. Sci Rep. 2022 Aug 3;12(1):13311. [PubMed]
16. Del Pinto R, Landi L, Grassi G, Sforza NM, Cairo F, Citterio F, et al. Italian working group on Hypertension, Periodontitis (Hy-Per Group). Hypertension and Periodontitis: A Joint Report by the Italian Society of Hypertension (SIIA) and the Italian Society of Periodontology and Implantology (SIdP). High Blood Press Cardiovasc Prev. 2021 Sep;28(5):427-438. [PubMed]
17. Rodriguez NM, Loren P, Paez I, Martínez C, Chaparro A, Salazar LA. MicroRNAs: The Missing Link between Hypertension and Periodontitis? Int J Mol Sci. 2024 Feb 6;25(4):1992. [PubMed]
Received: 22 December 2024
Published online: 09 Septtember 2025